Aromatase inhibitors - Theoretical concept and present experiences in the treatment of endometriosis;Aromatasehemmer - Theoretisches konzept und bisherige erfahrungen in der endometriosetherapie

Zentralblatt fur Gynakologie

Volumn 125, Issue 7-8, 2003, Pages 247-251

  Ebert, Andreas D ^a,b   Bartley, J ^c   David, M ^c   Schweppe, K W ^c  

^a DEKEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NONE

Author keywords

Aromatase; Cyclooxygenase; Endometriosis; Estradiol; Prostaglandins

Indexed keywords

ANASTROZOLE; ANDROGEN; AROMATASE; AROMATASE INHIBITOR; C19 ANDROGEN; CELECOXIB; CYCLOOXYGENASE 2; ESTRADIOL; ESTROGEN; ESTRONE; EXEMESTANE; LETROZOLE; PROSTAGLANDIN E2; ROFECOXIB; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL INVASION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME DEFICIENCY; ESTROGEN SYNTHESIS; FEEDBACK SYSTEM; FEMALE; GENE OVEREXPRESSION; HUMAN; IMPLANT; OVARY FUNCTION; PAIN; PREMENOPAUSE; PROSTAGLANDIN SYNTHESIS; RECURRENT DISEASE;

EID: 0141557957     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42517     Document Type: Article

References (36)

1. Alshafie GA, Abou-Issa HM, Seibert K, Harris RE. Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model. Oncol Rep 2000; 7: 1377-1381
2. Bhatnagar AS, Brodie AMH, Long BJ, Evans DB, Miller WR. Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J Steroid Biochem Mol Biol 2001; 76: 199-202
3. Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett 1999; 140: 27-35
4. Bulun SE, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, Johns Putman M, Sasano H. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocrine-Relat Cancer 1999; 6: 293-301
5. Bulun SE, Zeitoun KM, Takayama K, Sasano H. Molecular basis for treating endometriosis with aromatase inhibitors. Human Reprod Update 2000; 6: 413-418
6. Bulun SE, Zeitoun KM, Takayama K, Simpson E, Sasano H. Aromatase as a therapeutic target in endometriosis. Trends Endocrinol Metabol 2000; 11: 22-27
7. De Leon FD, Vijayakumar R, Brown M, Rao CV, Yussman MA, Schultz G. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis. Obstet Gynecol 1986; 68: 189-194
8. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP. Apoptosis in endometrial glandular and stromal cells in woman with and without endometriosis. Hum Reprod 2001; 16: 1802-1808
9. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188
10. Ebert AD, Schweppe KW, David M, Halis G, Lange J, Bouterfa H. Therapeutic use of the aromatase inhibitor letrozole in a premenopausal woman with endometriosis. In: II. world congress on controversies in obstetrics, gynecology and infertility. 2001; p. 33
11. FitzGerald GA, Patrono C. The Coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 433-442
12. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A. Invasiveness of endometriotic cells in vitro. Lancet 1995; 346: 1463-1464
13. Gately S. The contribution of cyclooxygenase-2 to tumor angiogenesis. Cancer Metatstasis Rev 2000; 19: 19-27
14. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of endometrial tissue is impaired in woman with endometriosis. Fertil Steril 1998; 69: 1042-1047
15. Goss PE, Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 2001; 19: 881-894
16. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 129: 125-140
17. Howe LR, Subbaramaiah K, Brown AMC, Dannenberg AJ. Cyclooxygenase-2: a target for prevention and treatment of breast cancer. Endomcrine-rel Cancer 2001; 8: 97-114
18. Husmann F. Sind die Aromatasehemmer therapeutische Alternativen oder Mittel der Wahl? Gyn 1999; 20: 293-298
19. Imai A, Takagi A, Tamaya T. Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. Am J Obstet Gynecol 2000; 182: 1142-1146
20. Jones RL, Kelly RW, Critchley HOD. Chemokine and cyclooxygenase-e expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 1997; 12: 1300-1306
21. Kelloff GJ, Lubet RA, Lieberman R, Eisenhauer K, Steele VE, Crowell JA, Hawk ET, Boone CW, Sigman CC. Aromatase inhibitors as potential cancer chemopreventives. Cancer Epid Biomarkers & Prev 1998; 7: 65-78
22. Kim SH, Choi YM, Chae HD, Kim KR, Kim CH, Kang BM. Increased expression of endoglin in the eutopic endometrium of woman with endometriosis. Fertil Steril 2001; 76: 918-922
23. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S, Honjo H. Detection of aromatase cytochrome p-450 in endometrioal biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999; 72: 1100-1106
24. Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod 2002; 17: 2725-2736
25. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001; 276: 18563-18569
26. McLaren J. Vascular endothelial grwoth factor and endometriotic angiogenesis. Hum Reprod Update 2000; 61: 45-55
27. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996; 81: 174-179
28. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997; 82: 600-606
29. Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med 2001; 345: 266-275
30. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Human Reprod 2001; 16: 561-566
31. Starzinski-Powitz A, Zeitvogel A, Schreiner A, Baumann R. In search of pathogenic mechanisms in endometriosis: the challange for molecular cell biology. Curr Mol Med 2001; 1: 633-642
32. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-1952
33. th SPORE Investigators Workshop 1999
34. Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998; 69: 709-713
35. Zeitoun KM, Bulun SE. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 1999; 72: 961-969
36. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. J Clin Endocrinol Metab 1998; 83: 4474-4480